MedTrace Logo

Study on the Response to Tetanus Vaccination of People Living With HIV

NCT03853681 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2020-10-05

No results posted yet for this study

Summary

The response to primary tetanus immunization of HIV-infected children is lower than that of uninfected children.

Response to tetanus toxoid (TT) booster doses in adults living with HIV who have received primary vaccination prior to infection is not known.

Currently, it is recommended to have a TT booster for people living with HIV (PLHIV) every 10 years. In general population, this recall is made only at 25, 45 and 65 years, then every 10 years.

Conditions

  • HIV Infections

Interventions

DIAGNOSTIC_TEST

additional blood sampling

additional blood sampling

Sponsors & Collaborators

  • Centre Hospitalier de Niort

    lead OTHER

Principal Investigators

  • Simon SUNDER, Doctor · Centre Hospitalier de Niort - France

  • Simon SUNDER, Doctor · CH Niort

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-11
Primary Completion
2019-09-11
Completion
2020-02-24

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03853681 on ClinicalTrials.gov